Amarin Corp Plc (AMRN)

[ziploc_1]

KM says that Amarin is working on two versions of a statin-Vascepa combo...

This might be a blister pack with a 20 mgm statin and 4 grams of Vascepa plus a blister pack with a 40 mgm statin and 4 grams of Vascepa....or some other combinations

Amarin could profit from the patent exclusivity of the fixed dose product and absorb the cost of the statin...making the price to the patient about equal to that of the Vascepa alone.

Amarin is presently developing a prototype and should be in manufacturing mode soon.

Since both the statin plus Vascepa have already been approved by the FDA, I doubt that further trials will be required.